NEW YORK (GenomeWeb News) – Population Genetics Technologies said today that it has secured a £2,000,000 ($3.2 million) investment from previous investors in the privately held genomics analysis technologies firm.

The company said it earned this second tranche of the Series A funding by meeting certain commercial and developmental milestones set by its principal investors.

The Cambridge, UK-based firm's initial seed funding came from the Wellcome Trust, and its Series A investors include Auriga Partners, Beringea, and Compass Genetics Investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.